Alterity Therapeutics Ltd. (AU:ATH) has released an update ... that track brain volume changes in Multiple System Atrophy (MSA) patients. These findings, which introduce the MSA Atrophy Index ...
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...
Alterity Therapeutics Ltd. (AU:ATH) has released an update. Alterity Therapeutics has unveiled promising data from its bioMUSE study at an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback